IVF Hartmann Holding AG
SIX:VBSN
Relative Value
The Relative Value of one
VBSN
stock under the Base Case scenario is
137.84
CHF.
Compared to the current market price of 143.5 CHF,
IVF Hartmann Holding AG
is
Overvalued by 4%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VBSN Competitors Multiples
IVF Hartmann Holding AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
IVF Hartmann Holding AG
SIX:VBSN
|
344.4m CHF | 2.2 | 18.1 | 9.2 | 11.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.2 | 37.5 | 27.1 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.7 | 39 | 15 | 29.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.3B DKK | 3.7 | 25.6 | 13.4 | 16 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD | 2.9 | 28.6 | 12.3 | 16.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.6 | 36 | 14.3 | 24.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.8B CNY | 9.2 | 25.3 | 22.8 | 22.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.9 | 17 | 55.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 3.3 | 21.9 | 14 | 17.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
819.6B JPY | 6.3 | 46.3 | 21.8 | 29.6 |